Xu, L., Kikuchi, E., Xu, C., Ebi, H., Ercan, D., Cheng, K. A., . . . Wong, K. (2012). Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers co-driven by mutant EGFR containing T790M and MET.
Stile di citazione ChicagoXu, Lu, et al. Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Co-driven By Mutant EGFR Containing T790M and MET. 2012.
Citazione MLAXu, Lu, et al. Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Co-driven By Mutant EGFR Containing T790M and MET. 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.